Involvement of DPP3 in modulating oncological features and oxidative stress response in esophageal squamous cell carcinoma
Bioscience Reports · 2023
DOI: 10.1042/bsr20222472 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioscience Reports, 2023. Verfasst von Mohit Arora und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DBT-Wellcome Trust India Alliance, Indian Council of Medical Research.
Abstract (Originalsprache)
Resistance to therapy in esophageal squamous cell carcinoma (ESCC) is a critical clinical problem and identification of novel therapeutic targets is highly warranted. Dipeptidyl peptidase III (DPP3) is a zinc-dependent aminopeptidase and functions in the terminal stages of the protein turnover. Several studies have reported overexpression and oncogenic functions of DPP3 in numerous malignancies. The present study aimed to determine the expression pattern and functional role of DPP3 in ESCC. DPP3 expression was assessed in normal and tumor tissues using quantitative real-time (qRT)-PCR and corroborated with ESCC gene expression datasets from Gene Expression Omnibus (GEO) and The cancer genome atlas (TCGA). DPP3 stable knockdown was performed in ESCC cells by shRNA and its effect on cell proliferation, migration, cell cycle, apoptosis, and activation of nuclear factor erythroid 2-related factor 2 (NRF2) pathway was assessed. The results suggested that DPP3 is overexpressed in ESCC and its knockdown leads to reduced proliferation, increased apoptosis, and inhibited migration of ESCC cells. Additionally, DPP3 knockdown leads to down-regulation of the NRF2 pathway proteins, such as NRF2, G6PD, and NQO1 along with increased sensitivity toward oxidative stress-induced cell death and chemotherapy. Conclusively, these results demonstrate critical role of DPP3 in ESCC and DPP3/NRF2 axis may serve as an attractive therapeutic target against chemoresistance in this malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
- Laboratory Oncology Unit, Dr. BRA-IRCH, All India Institute of Medical Sciences, New Delhi, India.
- Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.
- Department of Surgical Oncology, All India Institute of Medical Sciences, New Delhi, India.
- Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
ORCID-Profile: Mohit Arora, Sarita Kumari, Anurag Kumar, Anita Chopra, Shyam S Chauhan
Förderung
- DBT-Wellcome Trust India Alliance
- Indian Council of Medical Research
Zitieren
APA
Arora, M., Kumari, S., Kadian, L., Anupa, G., Singh, J., Kumar, A., Verma, D., Pramanik, R., Kumar, S., Yadav, R., Chopra, A., & Chauhan, S. S. (2023). Involvement of DPP3 in modulating oncological features and oxidative stress response in esophageal squamous cell carcinoma. Bioscience Reports. https://doi.org/10.1042/bsr20222472
Vancouver
Arora M, Kumari S, Kadian L, Anupa G, Singh J, Kumar A, et al. Involvement of DPP3 in modulating oncological features and oxidative stress response in esophageal squamous cell carcinoma. Bioscience Reports. 2023. doi:10.1042/bsr20222472
BibTeX
@article{Arora2023,
author = {Arora, Mohit and Kumari, Sarita and Kadian, Lokesh and Anupa, Geethadevi and Singh, Jay and Kumar, Anurag and Verma, Deepika and Pramanik, Raja and Kumar, Sunil and Yadav, Rajni and Chopra, Anita and Chauhan, Shyam S},
title = {Involvement of DPP3 in modulating oncological features and oxidative stress response in esophageal squamous cell carcinoma},
journal = {Bioscience Reports},
year = {2023},
doi = {10.1042/bsr20222472}
}
EUVIMED